Jasmeet Singh to Biosimilar Pharmaceuticals
This is a "connection" page, showing publications Jasmeet Singh has written about Biosimilar Pharmaceuticals.
Connection Strength
0.183
-
Perez EA, Dang C, Lee C, Singh J, Wang K, Layton JB, Gilsenan A, Hackshaw MD, Cortes J. Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review. Breast Cancer Res Treat. 2022 Jul; 194(1):1-11.
Score: 0.183